Unsaturated fatty acids differ between hepatic colorectal metastases and liver tissue without tumour in humans: Results from a randomised controlled trial of intravenous eicosapentaenoic and docosahexaenoic acids

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 6, 2013, Pages 405-410

  Stephenson, James A ^a   Al Taan, Omer ^a   Arshad, Ali ^a   West, Annette L ^b   Calder, Philip C ^b,c   Morgan, Bruno ^a   Metcalfe, Matthew S ^a   Dennison, Ashley R ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cancer; Fish oil; Liver tissue composition; N 3 PUFA; Tumour composition

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGA 9 FATTY ACID; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIVER METASTASIS; LIVER RESECTION; MALE; METASTATIC COLORECTAL CANCER; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84878020249     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.04.002     Document Type: Article

References (61)

1. Wendel M., Heller A.R. Anticancer actions of omega-3 fatty acids-current state and future perspectives. Anticancer Agents Med. Chem. 2009, 9:457-470.
2. Krishnamoorthy S., Honn K.V. Eicosanoids in tumor progression and metastasis. Subcell. Biochem. 2008, 49:145-168.
3. Koki A.T., Masferrer J.L. Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 2002, 9:28-35.
4. Sakai M., Kakutani S., Horikawa C., Tokuda H., Kawashima H., Shibata H., Okubo H., Sasaki S. Arachidonic acid and cancer risk: a systematic review of observational studies. BMC Cancer 2012, 12:606.
5. Kokoglu E., Tuter Y., Yazici Z., Sandikci K.S., Sonmez H., Ulakoglu E.Z., Ozyurt E. Profiles of the fatty acids in the plasma membrane of human brain tumors. Cancer Biochem. Biophys. 1998, 16:301-312.
6. Martin D.D., Robbins M.E., Spector A.A., Wen B.C., Hussey D.H. The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue. Lipids 1996, 31:1283-1288.
7. Reynolds L.M., Dalton C.F., Reynolds G.P. Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 2001, 309:193-196.
8. Gleissman H., Johnsen J.I., Kogner P. Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?. Exp. Cell Res. 2010, 316:1365-1373.
9. Marugame T., Kamo K., Katanoda K., Ajiki W., Sobue T. Cancer incidence and incidence rates in Japan in 2000: Estimates based on data from 11 population-based cancer registries. Jpn. J. Clin. Oncol. 2006, 36:668-675.
10. Norat T., Bingham S., Ferrari P., Sliman N., Jenab M., Mazuir M., Overvad K., Olsen A., Tjonneland A., Clavel F., Boutron-Ruault M., Kesse E., Boeing H., Bergmann M.M., Nieters A., Linseisen J., Trichopoulou A., Trichopoulos D., Tountas Y., Berrino F., Palli D., Panico S., Tumino R., Vineis P., Bueno-de- Mesquita H., Peeters P.H., Engeset D., Lund E., Skeie G., Ardanaz E., González Navarro C., Quirós J.R., Sanchez M.J., Berglund G., Mattisson I., Hallmans G., Palmqvist R., Day N.E., Khwat K., Key T.J., San Joaquin M., Hémon B., Saracci R., Kaaks R., Riboli E. Meat, fish, and colorectal cancer risk: the European prospective investigation into cancer and nutrition. J. Nat. Cancer Inst. 2005, 97:906-916.
11. Courtney E.D., Matthews S., Finlayson C., Di Pierro D., Belluzzi A., Roda E., Kang J.Y., Leicester R.J. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int. J. Colorectal Dis. 2007, 22:765-776.
12. Fradet V., Cheng I., Casey G., Witte J.S. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin. Cancer Res. 2009, 15:2559-2566.
13. Smith-Warner S.A., Spiegelman D., Ritz J., Albanes D., Beeson W.L., Bernstein L., Berrino F., van den Brandt P.A., Buring J.E., Cho E., Colditz G.A., Folsom A.R., Freudenheim J.L., Giovannucci E., Goldbohm R.A., Graham S., Harnack L., Horn-Ross P.L., Krogh V., Leitzmann M.F., McCullough M.L., Miller A.B., Rodriguez C., Rohan T.E., Schatzkin A., Shore R., Virtanen M., Willett W.C., Wolk A., Zeleniuch-Jacquotte A., Zhang S.M., Hunter D.J. Methods for pooling results of epidemiologic studies: the pooling project of prospective studies of diet and cancer. Am. J. Epidemiol. 2006, 63:1053-1064.
14. Thiebaut A.C., Chajes V., Gerber M., Boutron-Ruault M.C., Joulin V., Lenoir G., Berrino F., Riboli E., Benichou J., Clavel-Chapelon F. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int. J. Cancer 2009, 124:924-931.
15. Wolk A., Larsson S.C., Johansson J.E., Ekman P. Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA 2006, 296:1371-1376.
16. Dupertuis Y.M., Meguid M.M., Pichard C. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:427-432.
17. Hardman W.E. (n-3) Fatty acids and cancer therapy. J. Nutr. 2004, 134:3427S-3430S.
18. Roynette C.E., Calder P.C., Dupertuis Y.M., Pichard C. n-3 Polyunsaturated fatty acids and colon cancer prevention. Clin. Nutr. 2003, 23:139-151.
19. Hyman B.T., Spector A.A. Accumulation of N-3 polyunsaturated fatty acids cultured human Y79 retinoblastoma cells. J. Neurochem. 1981, 37:60-69.
20. Spector A.A., Steinberg D. Turnover and utilization of esterified fatty acids in Ehrlich ascites tumor cells. J. Biol. Chem. 1967, 242:3057-3062.
21. Petersen E.S., Kelley E.E., Modest E.J., Burns C.P. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440. Cancer Res. 1992, 52:6263-6269.
22. Burns C.P., Spector A.A. Membrane fatty acid modification in tumor cells: a potential therapeutic adjunct. Lipids 1987, 22:178-184.
23. Atkinson T.G., Murray L., Berry D.M., Rothig D.J., Meckling-Gill K.A. DHA feeding provides host protection and prevents fibrosarcoma-induced hyperlipidemia while maintaining the tumor response to araC in Fischer 344 rats. Nutr. Cancer 1997, 28:225-235.
24. Vartak S., Robbins M.E., Spector A.A. Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids 1997, 32:283-292.
25. Shao Y., Pardini L., Pardini R.S. Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide. Nutr. Cancer 1997, 28:63-73.
26. Sala-Vila A., Folkes J., Calder P.C. The effect of three lipid emulsions differing in fatty acid composition on growth, apoptosis and cell cycle arrest in the HT-29 colorectal cancer cell line. Clin. Nutr. 2010, 29:519-524.
27. Sauer L.A., Dauchy R.T., Blask D.E. Polyunsaturated fatty acids, melatonin, and cancer prevention. Biochem. Pharmacol. 2001, 61:1455-1462.
28. Menendez J.A., Vazquez-Martin A., Colomer R., Brunet J., Carrasco-Pancorbo A., Garcia-Villalba R., Fernandez-Gutierrez A., Segura-Carretero A. Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells BMC. Cancer 2007, 7:80.
29. Simopoulos A.P. The Mediterranean diets: what is so special about the diet of Greece? The scientific evidence. J. Nutr. 2001, 131:3065S-3073S.
30. Visioli F., Galli C. The role of antioxidants in the Mediterranean diet. Lipids 2001, 36:S49-S52.
31. Stark A.H., Madar Z. Olive oil as a functional food: epidemiology and nutritional approaches. Nutr. Rev. 2002, 60:170-176.
32. La Vecchia C. Mediterranean diet and cancer. Public Health Nutr. 2004, 7:965-968.
33. Martinez-Gonzalez M.A., Estruch R. Mediterranean diet, antioxidants and cancer: the need for randomized trials. Eur. J. Cancer Prev. 2004, 13:327-335.
34. Wahle K.W., Caruso D., Ochoa J.J., Quiles J.L. Olive oil and modulation of cell signaling in disease prevention. Lipids 2004, 39:1223-1231.
35. F. Perez-Jimenez, G. Alvarez de Cienfuegos, L. Badimon, G. Barja, M. Battino, A. Blanco, A. Bonanome, R. Colomer, D. Corella-Piquer, I. Covas, J. Chamorro-Quiros, E. Escrich, J.J. Gaforio, P.P. Garcia Luna, L. Hidalgo, A. Kafatos, P.M. Kris-Etherton, D. Lairon, R. Lamuela-Raventos, J. Lopez-Miranda, F. Lopez-Segura, M.A. Martinez-Gonzalez, P. Mata, J. Mataix, J. Ordovas, J. Osada, R. Pacheco-Reyes, M. Perucho, M. Pineda- Priego, J.L. Quiles, M.C. Ramirez-Tortosa, V. Ruiz-Gutierrez, P. Sanchez-Rovira, V. Solfrizzi, F. Soriguer-Escofet, R. de la Torre-Fornell, A. Trichopoulos, J.M. Villalba-Montoro, J.R. Villar-Ortiz, F. Visioli, International conference on the healthy effect of virgin olive oil, Eur. J. Clin. Invest. 2005 35 pp. 421-424.
36. Serra-Majem L., Roman B., Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr. Rev. 2006, 64:S27-S47.
37. Colomer R., Menendez J.A. Mediterranean diet, olive oil and cancer. Clin. Transl. Oncol. 2006, 8:15-21.
38. Menendez J.A., Lupu R. Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acidoleic acid (18:1n-9). Curr. Pharm. Biotechnol. 2006, 7:495-502.
39. Menendez J.A., Ropero S., Lupu R., Colomer R. Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells. Ann. Oncol. 2004, 15:1719-1721.
40. Menendez J.A., Vellon L., Colomer R., Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/ neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann. Oncol. 2005, 16:359-371.
41. Menendez J.A., Papadimitropoulou A., Vellon L., Lupu R. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory PEA3 transcription factor-PEA3 DNA binding site complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur. J. Cancer 2006, 42:2425-2432.
42. Neve R.M., Lane H.A., Hynes N.E. The role of overexpressed HER2 in transformation. Ann. Oncol. 2001, 12:S9-S13.
43. Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology 2001, 61:1-13.
44. Rubin I., Yarden Y. The basic biology of HER2. Ann. Oncol. 2001, 12:S3-S8.
45. Menard S., Pupa S.M., Campiglio M., Tagliabue E. Biological and therapeutic role of HER2 in cancer. Oncogene 2003, 22:6570-6578.
46. Takeshita M., Ueda H., Shirabe K., Higuchi Y., Yoshida S. Lack of promotion of colon carcinogenesis by high-oleic safflower oil. Cancer 1997, 79:1487-1493.
47. Bartolí R., Fernández-Bañares F., Navarro E., Castellà E., Mañé J., Alvarez M., Pastor C., Cabré E., Gassull M.A. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 2000, 46:191-199.
48. Ratnayake W.M.N., Galli C. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann. Nutr. Metab. 2009, 55:8-43.
49. Yaqoob P., Sherrington E.J., Jeffery N.M., Sanderson P., Harvey D.J., Newsholme E.A., Calder P.C. Comparison of the effects of a range of dietary lipids upon serum and tissue lipid composition in the rat. Int. J. Biochem. Cell Biol. 1995, 27:297-310.
50. Lamaziere A., Wolf C., Barbe U., Bausero P., Visioli F. Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88:149-154.
51. Katan M.B., Deslypere J.P., van Birgelen A.P., Penders M., Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 1997, 10:2012-2022.
52. Calder P.C., Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad. Med. 2009, 121:148-157.
53. Berstad P., Thiis-Evensen E., Vatn M.H., Almendingen K. Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients. J. Oncol. 2012, 254801.
54. Kokoglu E., Tüter Y., Sandikçi K.S., Yazici Z., Ulakoǧlu E.Z., Sönmez H., Ozyurt E. Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors. Cancer Lett. 1998, 132:17-21.
55. Szachowic-Petelska B., Sulkowski S., Figaszewski Z.A. Altered membrane free unsaturated fatty acid composition in human colorectal cancer tissue. Mol. Cell. Biochem. 2007, 294:237-242.
56. Baron A., Migita T., Tang D., Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer?. J. Cell. Biochem. 2004, 91:47-53.
57. Swinnen J.V., Brusselmans K., Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:358-365.
58. Flavin R., Peluso S., Nguyen P.L., Loda M. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 2010, 6:551-562.
59. Igal R.A. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010, 31:1509-1515.
60. Ok E., Yilmaz Z., Karakucuk I., Akgun H., Sahin H. Use of olive oil based emulsions as an alternative to soyabean oil based emulsions in total parenteral nutrition and their effects on liver regeneration following hepatic resection in rats. Ann. Nutr. Metab. 2003, 47:221-227.
61. Calder P.C., Davis J., Yaqoob P., Pala H., Thies F., Newsholme E.A. Dietary fish oil suppresses human colon tumour growth in athymic mice. Clin. Sci. 1998, 94:303-311.